SageView Advisory Group, LLC

Position in LLY — ELI LILLY & Co

CIK 1914558 NEWPORT BEACH, CA

Position in LLY

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$13,250,104

+$2,791,400 QoQ

Shares Held

11,047

-2.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.79%

of 13F equity value

Holder Rank

#1,106

of 4,605 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

SageView Advisory Group, LLC holds $31,073,717 across 11 Drug Manufacturers - General names. LLY ranks #1 (42.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	11,047	$13,250,104
2	JNJ	Johnson & Johnson	19,763	$5,019,209
3	ABBV	AbbVie Inc.	16,291	$4,099,467
4	MRK	Merck & Co., Inc.	25,250	$3,244,625
5	AMGN	Amgen Inc	4,580	$1,658,509
6	PFE	Pfizer Inc	51,687	$1,244,622
7	GILD	Gilead Sciences, Inc.	8,588	$1,085,007
8	BMY	Bristol Myers Squibb Co	9,232	$531,947

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,250,104	11,047	-2.8%	Shares	Sole	2026-08-10
2026-03-31	$10,458,704	11,371	-1.7%	Shares	Sole	2026-08-10
2025-12-31	$12,427,600	11,564	-4.7%	Shares	Sole	2026-02-17
2025-09-30	$9,256,716	12,132	+3.6%	Shares	Sole	2025-11-13
2025-06-30	$9,129,075	11,711	+4.8%	Shares	Sole	2025-08-13
2025-03-31	$9,227,066	11,172	-0.5%	Shares	Sole	2025-05-19
2024-12-31	$8,671,104	11,232	+2.1%	Shares	Sole	2025-02-13
2024-09-30	$9,747,111	11,002	-17.2%	Shares	Sole	2024-11-14
2024-06-30	$12,027,973	13,285	+16.9%	Shares	Sole	2024-08-15
2024-03-31	$8,842,293	11,366	-12.6%	Shares	Sole	2024-05-09
2023-12-31	$7,584,955	13,012	+37.8%	Shares	Sole	2024-03-06
2023-09-30	$5,072,655	9,444	+0.7%	Shares	Sole	2023-11-03
2023-06-30	$4,397,625	9,377	+13.4%	Shares	Sole	2023-08-11
2023-03-31	$2,840,083	8,270	+3.8%	Shares	Sole	2023-05-02
2022-12-31	$2,914,647	7,967	—	Shares	Sole	2023-02-15
No filing history on record for this holder in this stock.